CClinicalTrials.gg
CompletedNCT03588559CT_1591-AUpdated Jul 17, 2018

Clinical Trial of Blood Pressure Monitor in Conformance With the ANSI/AAMI ISO 81060-2 Standard

An interventional study of Blood Pressure Measurement in Blood Pressure, sponsored by BTS International. Completed at 1 site in United States. Open to participants aged 3 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-07-17.

Sponsored by BTS International · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Primary completion was Jun 2017, 9 years 3 months ago, and no results have been posted to the registry.
  • Registered 1 year after the study started (first participant enrolled May 2017, registered Jun 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
88
Allocation
Not applicable
Ages
3 Years and older
Sex
All
01

Study summary

The clinical protocol of the trial:

  1. Objective of the trial: To assess the accuracy of device.
  2. Test methods and procedures: Perform comparation test on seated position by two devices at the same time.
  3. DUT: Transtek Blood Pressure Monitor, Model TMB-1591-A-002, with Cuff (sizes, cm) 15-21, 20-26, 25-34, 25-34(L), 32-43, 32-43(L), 40-55.
  4. Reference device: Baumanometer Desk Mercury Sphygmomanometer.
  5. Study endpoints: Comply with ANSI/AAMI ISO 81060-2:2013 standard.
  6. Statistical methodology used: Standard deviation, Mean error.
Read the detailed description
  1. Introduction:

    Automated blood pressure cuff measurement is the standard of care in numerous medical settings today. This study was designed to assess the accuracy of a previously cleared automated blood pressure cuff system using the same arm sequential dual observer auscultation method. The study was conducted in accordance to ANSI/AAMI/ISO 81060-2:2013 Non-invasive sphygmomanometers - Part 2: Clinical investigation of automated measurement type, the Code of Federal Regulations requirements for Non-Significant Risk Device Investigations and as appropriate ISO 14155: Clinical investigation of medical devices for human subjects - Good clinical practice.

  2. Purpose of Clinical Investigation:

    The purpose of this study is to provide supporting documentation for non-invasive blood pressure measurement Accuracy claims for the TMB-1591-A-002 Blood Pressure System with Reusable Cuffs on the intended adult and pediatric population.

  3. Clinical Investigation Population:

    Following Salus Independent Review Board (IRB) approval, a total of 90 subjects were screened and enrolled into the study and data was collected. Two subjects were withdrawn from the study and the data was not used in the data analysis. These subjects were removed due to difficulty in hearing the reference blood pressure range (systolic and/or diastolic) and the other was removed due an unstable systolic range. A total of 88 healthy subjects, (53 adult / adolescent and 35 pediatric) ages 3-75yr, arm circumference 15-49.5 cm, systolic blood pressures ranges 79-176.5 and diastolic blood pressure ranges of 49-116 were included in the study for analysis. The study was conducted May 30 - June 16, 2017 to perform an accuracy validation on TMB-1591-A-002 Blood Pressure System with FlexiPortTM Reusable Cuffs.

  4. Method:

The requirements for the study were to include a minimum of 85 subjects with a minimum of 35 pediatric subjects 3-12 years of age and the remainder over 12 years of age, with at least 30% being male and 30% being female, and an arm circumference range of 15-55cm where at least six subjects were evaluated in each of the seven cuffs. For the data collection, at least 90% of the subjects needed to contribute 3 paired observations allowing the remaining 10% to be 2 paired observations. A minimum of 255 valid paired observations were needed for the analysis.

This study utilized the same arm sequential method (Dual Observer) in which the observers alternated the measurements for the reference sphygmomanometer and the sphygmomanometer-under test. Each paired reading incorporated the average of the reference reading prior to the device under test and after the device under test. (ANSI/AAMI/ISO 81060-2:2013, Section 5.2.4.2).

The TMB-1591-A-002 Blood Pressure System with FlexiPortTM Reusable Cuffs, (sphygmomanometer-under-test) was designed for use on the upper arm of patients with arm circumferences that range from 15-55cm. Seven cuff sizes were included in the investigation requiring that each cuff size have data collection on at least 6 subjects. Two trained observers (auscultators) simultaneously observed (listened to) the Korotkoff sounds at the brachial artery during the automated blood pressure cuff measurement. The 5th Korotkoff (K5) sound was used to identify diastole for the adult/adolescent subjects and the 4th Korotkoff (K4) sound was used for the pediatric subjects.

The reference sphygmomanometer used in this study [Baumanometer Desk Mercury Sphygmomanometer, SN: CT1573] complied with the requirements of ISO 81060-1 (the maximum error was 1 mmHg per NIST traceable calibration verification.

02

Conditions studied

  • Blood Pressure

Keywords

  • Monitors, Blood Pressure
03

In context

Lead sponsor

BTS International is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria: male,female. Exclusion Criteria: below 3 years old.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
88 participants (actual)

Study arms

  • Experimental
    BPM, TMB-1591-A-002 and Reference Device

    DUT: Transtek Blood Pressure Monitor TMB-1591-A-002 Reference Device: Baumanometer Desk Mercury Sphygmomanometer. Blood Pressure Measurement with the Transtek BPM TMB-1591-A-002 and with reference device.

    Diagnostic Test: Blood Pressure Measurement

Interventions

  • Diagnostic testBlood Pressure Measurement

    Measurement blood pressure by Transtek BPM TMB-1591-A-002 and reference device.

    Also known as: Transtek TMB-1591-A-002 and reference device, blood pressure

06

What researchers measure

Primary outcomes

  1. Blood pressure measurement data

    Systolic Pressure and Diastolic Pressure

    Time frame: 30 minutes

07

Study locations

1 site
  • Clinimark, LLC
    Louisville, Colorado 80027, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 17, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03588559
Lead sponsor
BTS International
Collaborators
Clinimark, LLC, Guangdong Transtek Medical Electronics Co., Ltd.
Responsible party
Sponsor
First posted
Jul 17, 2018
Start date
May 30, 2017
Primary completion
Jun 16, 2017
Completion
Apr 23, 2018
Last update
Jul 17, 2018

Study contacts

Nagulinie Shukla
study chair · Clinimark, LLC

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion